The role of hypocretin in driving arousal and goal-oriented behaviors

Brain Research

Volumn 1314, Issue , 2010, Pages 103-111

  Boutrel, Benjamin ^a   Cannella, Nazzareno ^b   de Lecea, Luis ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Addiction; Drug seeking; Hypothalamus; Neuropeptide; Optogenetic; Orexin

Indexed keywords

OREXIN;

AROUSAL; ARTICLE; COGNITION; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; FOOD INTAKE; GOAL ATTAINMENT; HUMAN; LATERAL HYPOTHALAMUS; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REWARD; SLEEP DISORDER; SURVIVAL; WITHDRAWAL SYNDROME;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; AROUSAL; BEHAVIOR, ANIMAL; GOALS; HUMANS; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOTIVATION; NEUROPEPTIDES; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 75449095217     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.11.054     Document Type: Article

References (98)

1. Adamantidis A., and de Lecea L. Physiological arousal: a role for hypothalamic systems. Cell Mol. Life Sci. 65 (2008) 1475-1488
2. Adamantidis A., and de Lecea L. The hypocretins as sensors for metabolism and arousal. J. Physiol. 587 (2009) 33-40
3. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., and de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450 (2007) 420-424
4. Aston-Jones G., Smith R.J., Moorman D.E., and Richardson K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56 Suppl. 1 (2009) 112-121
5. Baldo B.A., Daniel R.A., Berridge C.W., and Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol. 464 (2003) 220-237
6. Bayer L., Serafin M., Eggermann E., Saint-Mleux B., Machard D., Jones B.E., and Mühlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J. Neurosci. 24 (2004) 6760-6764
7. Berridge, C.W., España, R.A., Vittoz, N.M., this issue. Hypocretin/orexin in arousal and stress. Brain Res.
8. Borgland S.L., Chang S.J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., Chou J., Chen B.T., and Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 29 (2009) 11215-11225
9. Borgland S.L., Taha S.A., Sarti F., Fields H.L., and Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 (2006) 589-601
10. Boschen K.E., Fadel J.R., and Burk J.A. Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats. Psychopharmacology 206 (2009) 205-213
11. Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br. J. Pharmacol. 154 (2008) 343-357
12. Boutrel B., and de Lecea L. Addiction and arousal: the hypocretin connection. Physiol. Behav. 93 (2008) 947-951
13. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., and de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19168-19173
14. Carr D., and Kalivas P.W. Orexin: a gatekeeper of addiction. Nat. Med. 12 (2006) 274-276
15. Carter M.E., Adamantidis A., Ohtsu H., Deisseroth K., and de Lecea L. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J. Neurosci. 29 (2009) 10939-10949
16. Carter M.E., Schaich Borg J., and de Lecea L. The brain hypocretins and their receptors: mediators of allostatic arousal. Curr. Opin. Pharmacol. 9 (2009) 39-45
17. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
18. Chung S., Hopf F.W., Nagasaki H., Li C.Y., Belluzzi J.D., Bonci A., and Civelli O. The melanin-concentrating hormone system modulates cocaine reward. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 6772-6777
19. Chang G.Q., Karatayev O., Davydova Z., and Leibowitz S.F. Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus. Endocrinology 145 (2004) 3904-3912
20. Corrigall, W.A., 2009. Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology 206, 23-37.
21. D'Anna K.L., and Gammie S.C. Hypocretin-1 dose-dependently modulates maternal behaviour in mice. J. Neuroendocrinol. 18 (2006) 553-566
22. Dayas C.V., McGranahan T.M., Martin-Fardon R., and Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol. Psychiatry 63 (2008) 152-157
23. Davis J.F., Krause E.G., Melhorn S.J., Sakai R.R., and Benoit S.C. Dominant rats are natural risk takers and display increased motivation for food reward. Neuroscience 162 (2009) 23-30
24. In: de Lecea L., and Sutcliffe J.G. (Eds). Hypocretins: Integrators of Physiological Functions (2005), Springer, New York
25. DiLeone R.J., Georgescu D., and Nestler E.J. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci. 73 (2003) 759-768
26. Eggermann E., Serafin M., Bayer L., Machard D., Saint-Mleux B., Jones B.E., and Mühlethaler M. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 108 (2001) 177-181
27. Epping-Jordan M.P., Watkins S.S., Koob G.F., and Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 39 (1998) 76-79
28. Espana R.A., Baldo B.A., Kelley A.E., and Berridge C.W. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106 (2001) 699-715
29. Fadel J., Bubser M., and Deutch A.Y. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J. Neurosci. 22 (2002) 6742-6746
30. Fu L.Y., Acuna-Goycolea C., and van den Pol A.N. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 24 (2004) 8741-8751
31. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., Yanagisawa M., Nestler E.J., and DiLeone R.J. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 23 (2003) 3106-3111
32. Gulia K.K., Mallick H.N., and Kumar V.M. Orexin A (hypocretin-1) application at the medial preoptic area potentiates male sexual behavior in rats. Neuroscience 116 (2003) 921-923
33. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., and Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30 (2001) 345-354
34. Harris G.C., Wimmer M., and Jones G.A. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (2005) 556-559
35. Hollander J.A., Lu Q., Cameron M.D., Kamenecka T.M., and Kenny P.J. Insular hypocretin transmission regulates nicotine reward. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 19480-19485
36. Huang H., Ghosh P., and van den Pol A.N. Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. J. Neurophysiol. 95 (2006) 1568-1656
37. Hyman S.E. Addiction: a disease of learning and memory. Am. J. Psychiatry 162 (2005) 1414-1422
38. Jahng J.W., Kim J.G., Kim H.J., Kim B.T., Kang D.W., and Lee J.H. Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter. Brain Res. 1150 (2007) 100-107
39. Jaworski J.N., Hansen S.T., Kuhar M.J., and Mark G.P. Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats. Behav. Brain Res. 191 (2008) 266-271
40. Kelz M.B., Sun Y., Chen J., Cheng Meng Q., Moore J.T., Veasey S.C., Dixon S., Thornton M., Funato H., and Yanagisawa M. An essential role for orexins in emergence from general anesthesia. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 1309-1314
41. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
42. Knutson B., Fong G.W., Adams C.M., Varner J.L., and Hommer D. Dissociation of reward anticipation and outcome with event-related fMRI. NeuroReport 12 (2001) 3683-3687
43. Knutson B., Rick S., Wimmer G.E., Prelec D., and Loewenstein G. Neural predictors of purchases. Neuron 53 (2007) 147-156
44. Kunii K., Yamanaka A., Nambu T., Matsuzaki I., Goto K., and Sakurai T. Orexins/hypocretins regulate drinking behaviour. Brain Res. 842 (1999) 256-261
45. Lambe E.K., and Aghajanian G.K. Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40 (2003) 139-150
46. Lambe E.K., Picciotto M.R., and Aghajanian G.K. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28 (2003) 216-225
47. Lambe E.K., Olausson P., Horst N.K., Taylor J.R., and Aghajanian G.K. Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J. Neurosci. 25 (2005) 5225-5229
48. Lawrence, A.J, this issue. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Q13 Brain Res.
49. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., and Oldfield B. The orexin system regulates alcohol-seeking in rats. Br. J. Pharmacol. 148 (2006) 752-759
50. Leri F., Zhou Y., Goddard B., Levy A., Jacklin D., and Kreek M.J. Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain. Eur. Neuropsychopharmacol. 19 (2009) 238-249
51. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., and Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (1999) 365-376
52. Lutter M., Krishnan V., Russo S.J., Jung S., McClung C.A., and Nestler E.J. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J. Neurosci. 28 (2008) 3071-3075
53. Macey D.J., Koob G.F., and Markou A. CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res. 866 (2000) 82-91
54. McEwen B.S., and Wingfield J.C. The concept of allostasis in biology and biomedicine. Horm. Behav. 43 (2003) 2-15
55. McPherson C.S., Featherby T., Krstew E., and Andrew J.L. Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons. J. Pharmacol. Exp. Ther. 323 (2007) 805-812
56. Markou A., and Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4 (1991) 17-26
57. Martin-Fardon, R. and Weiss, F., 2009. Differential effects of an Orx/Hcrt antagonist on reinstatement induced by a cue conditioned to cocaine versus palatable natural reward. Society for Neuroscience Meeting, Chicago, poster 65.21.
58. Mileykovskiy B.Y., Kiyashchenko L.I., and Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46 (2005) 696-698
59. Muschamp J.W., Dominguez J.M., Sato S.M., Shen R.Y., and Hull E.M. A role for hypocretin (orexin) in male sexual behavior. J. Neurosci. 27 (2007) 2837-2845
60. Nair S.G., Golden S.A., and Shaham Y. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br. J. Pharmacol. 154 (2008) 406-416
61. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., and Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 26 (2006) 398-405
62. Nishino S., Ripley B., Overeem S., Lammers G.J., and Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
63. Paulus M.P., and Stein M.B. An insular view of anxiety. Biol. Psychiatry 60 (2006) 383-387
64. Paulus M.P., Rogalsky C., Simmons A., Feinstein J.S., and Stein M.B. Increased activation in the right insula during risk-taking decision making is related to harm avoidance and neuroticism. NeuroImage 19 (2003) 1439-1448
65. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., and Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6 (2000) 991-997
66. Piper D.C., Upton N., Smith M.I., and Hunter A.J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12 (2000) 726-730
67. Pissios P., Frank L., Kennedy A.R., Porter D.R., Marino F.E., Liu F.F., Pothos E.N., and Maratos-Flier E. Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice. Biol. Psychiatry 64 (2008) 184-191
68. Rao Y., Lu M., Ge F., Marsh D.J., Qian S., Wang A.H., Picciotto M.R., and Gao X.B. Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus. J. Neurosci. 28 (2008) 9101-9110
69. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., and Bartlett S.E. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199 (2008) 109-117
70. Rieger M., Mayer G., and Gauggel S. Attention deficits in patients with narcolepsy. Sleep 26 (2003) 36-43
71. Rodgers R.J., Halford J.C., Nunes de Souza R.L., Canto de Souza A.L., Piper D.C., Arch J.R., Upton N., Porter R.A., Johns A., and Blundell J.E. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur. J. Neurosci. 13 (2001) 1444-1452
72. Russell S.H., Small C.J., Kennedy A.R., Stanley S.A., Seth A., Murphy K.G., Taheri S., Ghatei M.A., and Bloom S.R. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 142 (2001) 5294-5302
73. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev., Neurosci. 8 (2007) 171-181
74. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
75. Samson W.K., Bagley S.L., Ferguson A.V., and White M.M. Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. Am. J. Physiol., Regul. Integr. Comp. Physiol. 292 (2007) R382-R387
76. Shalev, U., Erb, S., Shaham, Q11 Y., this issue. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res.
77. Schneider E.R., Rada P., Darby R.D., Leibowitz S.F., and Hoebel B.G. Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcohol Clin. Exp. Res. 31 (2007) 1858-1865
78. Sharf R., Sarhan M., and DiLeone R.J. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol. Psychiatry 64 (2008) 175-183
79. Sjulson L., and Miesenbock G. Photocontrol of neural activity: biophysical mechanisms and performance in vivo. Chem. Rev. 108 (2008) 1588-1602
80. Smith R.J., See R.E., and Aston-Jones G. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur. J. Neurosci. 30 (2009) 493-503
81. Smith R.J., Tahsili-Fahadan P., and Aston-Jones G. Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 58 (2010) 179-184
82. Sutcliffe J.G., and de Lecea L. The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 3 (2002) 339-349
83. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., and Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2001) 469-474
84. Thiele T.E., Sparta D.R., Hayes D.M., and Fee J.R. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 38 (2004) 235-243
85. Thorpe A.J., Cleary J.P., Levine A.S., and Kotz C.M. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology (Berl) (2005) 1-9
86. Tsai H.C., Zhang F., Adamantidis A., Stuber G.D., Bonci A., de Lecea L., and Deisseroth K. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324 (2009) 1080-1084
87. Tsujino N., and Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol. Rev. 61 (2009) 162-176
88. van den Pol A.N. Narcolepsy: a neurodegenerative disease of the hypocretin system?. Neuron 27 (2000) 415-418
89. Vicentic A., and Jones D.C. The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. J. Pharmacol. Exp. Ther. 320 (2007) 499-506
90. Wang B., You Z.B., and Wise R.A. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol. Psychiatry 65 (2009) 857-862
91. 2. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10685-10690
92. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., and de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24 (2004) 11439-11448
93. Wise R.A. A new Peptide input to learning and addiction. Neuron 49 (2006) 483-484
94. Yamanaka A., Beuckmann C.T., Willie JT., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., and Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38 (2003) 701-713
95. Yoshida K., McCormack S., Espana R.A., Crocker A., and Scammell T.E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494 (2006) 845-861
96. Zhang F., Wang L.P., Boyden E.S., and Deisseroth K. Channelrhodopsin-2 and optical control of excitable cells. Nat. Methods 3 (2006) 785-792
97. Zhang F., Aravanis A.M., Adamantidis A., de Lecea L., and Deisseroth K. Circuit-breakers: optical technologies for probing neural signals and systems. Nat. Rev., Neurosci. 8 (2007) 577-581
98. Zhou Y., Bendor J., Hofmann L., Randesi M., Ho A., and Kreek M.J. Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J. Endocrinol. 191 (2006) 137-145